secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENERON PHARMACEUTICALS, INC. (REGN)
CIK:        0000872589
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0001104659-22-071446
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron shareholders re-elect four Class I directors, approve auditor, advisory pay vote at 2022 annual meeting
--------------------------------------------------------------------------------

- Board nominees Bassler, Brown, Schleifer, Yancopoulos re-elected with 96.9M, 86.3M, 110.1M, 109.5M votes for, respectively.
- Ratification of PwC as independent auditor for FY2022 approved: 111.8M for, 4.5M against.
- Advisory vote on named executive officer compensation approved: 97.8M for, 13.6M against, 4.7M broker non-votes.
- All three proposals passed; no contested items or shareholder proposals on ballot.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872589/000110465922071446/0001104659-22-071446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872589/000110465922071446/tm2218439d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-071446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer